Patent · US Active

Compositions and methods for assessing and treating adrenal diseases and disorders

US9982026B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

Yale University · US

Inventors

Richard P. Lifton · Guilford, US
Bixiao Zhao · Plainsboro, US
Murim Choi · Seoul, KR
Goran Akerstrom · Uppsala, SE
Gunnar Westin · Uppsala, SE
Peyman Bjorklund · Stockholm, SE
Per Hellman · Uppsala, SE

Key dates

Filing date	Jan 4, 2012
Grant date	May 29, 2018
Priority date	—
Expiry date	Jan 4, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the discovery that mutations in KCNJ5 are associated with adrenal diseases and disorders. The invention includes compositions and methods for the assessment, characterization and treatment of adrenal diseases and disorders, based upon the presence or absence of a KCNJ5 mutation that is associated with an adrenal disease or disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.